Supporting Information (Part II) for ACS Combinatorial Science

Similar documents
Using AutoDock for Virtual Screening

Computational Methods and Drug-Likeness. Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004

Advanced Medicinal Chemistry SLIDES B

Structural biology and drug design: An overview

Plan. Day 2: Exercise on MHC molecules.

In Silico Design of New Drugs for Myeloid Leukemia Treatment

ASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS

Hydrogen Bonding & Molecular Design Peter

JCICS Major Research Areas

Introduction to Chemoinformatics and Drug Discovery

Alkane/water partition coefficients and hydrogen bonding. Peter Kenny

Easier and Better Exploitation of PhysChem Properties in Medicinal Chemistry

Application integration: Providing coherent drug discovery solutions

Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.

ChemBioNet: Chemical Biology supported by Networks of Chemists and Biologists. Affinity Proteomics Meeting Alpbach. Michael Lisurek 15.3.

Targeting protein-protein interactions: A hot topic in drug discovery

Introduction. OntoChem

KNIME-based scoring functions in Muse 3.0. KNIME User Group Meeting 2013 Fabian Bös

molecules ISSN

Chemical library design

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007

BioSolveIT. A Combinatorial Approach for Handling of Protonation and Tautomer Ambiguities in Docking Experiments

Lead- and drug-like compounds: the rule-of-five revolution

Receptor Based Drug Design (1)

The Changing Requirements for Informatics Systems During the Growth of a Collaborative Drug Discovery Service Company. Sally Rose BioFocus plc

FRAUNHOFER IME SCREENINGPORT

Chemical Space. Space, Diversity, and Synthesis. Jeremy Henle, 4/23/2013

Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters

Chem 2320 Exam 1. January 30, (Please print)

Bioisosteres in Medicinal Chemistry

Drug Informatics for Chemical Genomics...


Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Translating Methods from Pharma to Flavours & Fragrances

Navigation in Chemical Space Towards Biological Activity. Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland

DivCalc: A Utility for Diversity Analysis and Compound Sampling

In silico pharmacology for drug discovery

Similarity Search. Uwe Koch

Chemoinformatics and Drug Discovery

MRP. parallel artificial membrane permeation assay (PAMPA) Caco-,

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences

ChemDiv Beyond the Flatland 3D-Fragment Library for Fragment-Based Drug Discovery (FBDD)

PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS

Combinatorial chemistry is now widely used to synthesize

Evolution of toxic properties of Anti Alzheimer s Drugs through Lipinski s rule of five

Dongyue Cao,, Junmei Wang,, Rui Zhou, Youyong Li, Huidong Yu, and Tingjun Hou*,, INTRODUCTION

Synthetic organic compounds

Identifying Promising Compounds in Drug Discovery: Genetic Algorithms and Some New Statistical Techniques

Enamine Golden Fragment Library

Biologically Relevant Molecular Comparisons. Mark Mackey

Quest for the Rings. In Silico Exploration of Ring Universe To Identify Novel Bioactive Heteroaromatic Scaffolds

Rules for drug discovery: can simple property criteria help you to find a drug?

Flow of information in a drug discovery pipeline. 7th lecture Modern Methods in Drug Discovery WS16/17 1

Molecular docking, 3D-QSAR studies of indole hydrazone as Staphylococcus aureus pyruvate kinase inhibitor

Compound Acquisition Strategies

ADME Evaluation in Drug Discovery. 8. The Prediction of Human Intestinal Absorption by a Support Vector Machine

Important Aspects of Fragment Screening Collection Design

ADME evaluation in drug discovery

Synthetic organic compounds

Principles of Drug Design

Chem 1140; Molecular Modeling

Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds

ICM-Chemist How-To Guide. Version 3.6-1g Last Updated 12/01/2009

AMRI COMPOUND LIBRARY CONSORTIUM: A NOVEL WAY TO FILL YOUR DRUG PIPELINE

LIBRARY DESIGN FOR COLLABORATIVE DRUG DISCOVERY: EXPANDING DRUGGABLE CHEMOGENOMIC SPACE

Chem 241. Lecture 23. UMass Amherst Biochemistry... Teaching Initiative

molecules ISSN

Automated Compound Collection Enhancement: how Pipeline Pilot preserved our sanity. Darren Green GSK

Parallel Synthesis of a Library of Symmetricallyand Dissymmetrically-Disubstituted Imidazole-4, 5- Dicarboxamides Bearing Amino Acid Esters

Introduction to Fragment-based Drug Discovery

Considering the Impact of Drug-like Properties on the Chance of Success

bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012

Bridging the Dimensions:

This doctoral thesis is based on the following papers, which will be referred to in the text by their Roman numerals (I-V):

How Diverse Are Diversity Assessment Methods? A Comparative Analysis and Benchmarking of Molecular Descriptor Space

Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted?

Exploring the chemical space of screening results

LigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer

Biochemistry,530:,, Introduc5on,to,Structural,Biology, Autumn,Quarter,2015,

Chem 263 Notes Sept. 26, 2013

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Hit to Lead Michael Rafferty

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

Virtual screening in drug discovery

Analysis of a Large Structure/Biological Activity. Data Set Using Recursive Partitioning and. Simulated Annealing

Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA

Overview. Descriptors. Definition. Descriptors. Overview 2D-QSAR. Number Vector Function. Physicochemical property (log P) Atom

Chem 5 PAL Worksheet Acids and Bases Smith text Chapter 8

Interactive Feature Selection with

Comparison of log P/D with bio-mimetic properties

Open PHACTS Explorer: Compound by Name

Analyzing Small Molecule Data in R

Relative Drug Likelihood: Going beyond Drug-Likeness

Portable Raman Spectroscopy for the Study of Polymorphs and Monitoring Polymorphic Transitions

Patrick: An Introduction to Medicinal Chemistry 5e Chapter 01

Saba Al Fayoumi. Tamer Barakat. Dr. Mamoun Ahram + Dr. Diala Abu-Hassan

CHAPTER 3. Pharmacophore modelling studies:

Intramolecular Hydrogen Bonding to Improve Membrane Permeability and Absorption in Beyond Rule of Five Chemical Space

Stephen McDonald and Mark D. Wrona Waters Corporation, Milford, MA, USA INT RO DU C T ION. Batch-from-Structure Analysis WAT E R S SO LU T IONS

Transcription:

Supporting Information (Part II) for ACS Combinatorial Science Application of 6,7Indole Aryne Cycloaddition and Pd(0)Catalyzed SuzukiMiyaura and BuchwaldHartwig CrossCoupling Reactions for the Preparation of Annulated Indole Libraries Paul D. Thornton, 2 Neil Brown, 1,2 David Hill, 2 Ben Neuenswander, 2 Gerald H. Lushington, 2 Conrad Santini 2 and Keith R. Buszek 1,2* 1 Department of Chemistry, University of Missouri, 5100 Rockhill Road, Kansas City, MO 64110 2 Center of Excellence in Chemical Methodologies and Library Development, University of Kansas, 2034 Becker Drive, Lawrence, KS 66047 Email: buszekk@umkc.edu Contents: 1. General experimental procedures: S2S3 a. General: S2 b. Procedure for SuzukiMiyaura CrossCoupling Reactions: S2S3 c. Procedure for BuchwaldHartwig CrossCoupling Reactions: S3 2. Tabulated 1H and 13C NMR for scaffolds and representative library members: S3S7 a. Furan scaffold, 19 b. Cyclopentadiene (Cp) scaffold, 18 c. Cp scaffold, SuzukiMiyaura members: 24{6}, 24{10}, 24{9}, 24{5}, 24{1} d. Furan scaffold, SuzukiMiyaura members: 21{28}, 21{20}, 21{24}, 21{25}, 21{18} e. Cp scaffold, BuchwaldHartwig members: 25{7}, 25{10}, 25{11}, 25{5}, 25{3}, 25{1} f. Furan scaffold, BuchwaldHartwig members: 23{10}, 23{18}, 23(11), 23{14} 3. Scaffold spectra: S8S11 a. Furan scaffold, 19 b. Cp scaffold, 18 4. Select 1H and 13C NMR data for representative library members: S12S53 S1

a. Cp scaffold, SuzukiMiyaura members: 24{6}, 24{10}, 24{9}, 24{5}, 24{1} b. Furan scaffold, SuzukiMiyaura members: 21{28}, 21{20}, 21{24}, 21{25}, 21{18} c. Cp scaffold, BuchwaldHartwig members: 25{7}, 25{10}, 25{11}, 25{5}, 25{3}, 25{1} d. Furan scaffold, BuchwaldHartwig members: 23{10}, 23{18}, 23(11), 23{14} 5. Method used for in silico analysis: See Supporting Information, Part II, S2S3. 6. Computed in silico parameters (Table 1): See Supporting Information, Part II, S4S9. 5. Method used for in silico analysis Sketched electronic versions of the library compounds were imported into the Tripos Molecular Spreadsheet [1] wherein standard Lipinski Rule of 5 parameters (molecular weight, ClogP, number of Hacceptors, and number of Hdonors[2]) plus the number of rotatable bonds and polar surface area were computed. Lipinski violations were specified according to molecular weight > 500, ClogP > 5.0, number of acceptors > 10, number of donors > 5, and number of rotatable bonds > 5. The structures were then exported into SDF format and coverted into threedimensional protonated structures via Concord [3]. Absorption, distribution, metabolism and excretion (ADME) profiles of these compounds was then generated via Volsurf [4]. Descriptors were generated using three probes (water, hydrophobic and carbonyl oxygen) with a grid space distribution of 1.0 Å. Predictions were then projected onto internal ADME models at the 5component level. Finally diversity analysis was carried out using DiverseSolutions [5] using standard H aware 3D BCUT descriptors. The library was then projected onto a chemical space defined by the following descriptors: gastchrg_invdist2_000.550_k_l, gastchrg_invdist6_000.500_k_h, haccept_invdist2_001.000_k_h, tabpolar_invdist_000.250_k_h, tabpolar_invdist_000.500_k_l and populated (for comparison) by a recent version of the MLSMR screening set (ca. 7/2010; S2

~330,000 unique chemical structures). Diversity scores (div(a)) for our library were then generated for each of our compounds (A) according to the expression: div( A) = pop[ Cell( A)] pop( i) /! i" Occ N occ where N occ is the number of cells occupied by PubChem compounds in an evenly distributed 10 10 10 10 10 grid decomposition of the chemistry space, and pop(i) is the population of cell i. REFERENCES [1] SYBYL 8.0, The Tripos Associates, St. Louis MO, 2008. [2] Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 325. [3] Concord 8.0, The Tripos Associates, St. Louis MO, 2008. [4] Cruciani, G., Meniconi, M., Carosati, E., Zamora, I., Mannhold, R. VOLSURF: A Tool for Drug ADMEProperties Prediction. In: Methods and Principles in Medicinal Chemistry. Eds. van de Waterbeemd, H., Lennernäs, H., Artursson, P. (WileyVCH Verlag GmbH & Co., Weinheim, 2003). [5] Pearlman, R.S.; Smith, K.M. Metric Validation and the ReceptorRelevant Subspace Concept. J. Chem. Inf. Comput. Sci. 1999, 39, 2835. 6. Computed in silico parameters (Table 1) S3

Molecule CLOGP Mol.Wt H acc H don 2501 4.70 287.36 1 1 2 0 87.09 0.16 1.20 2502 6.23 327.34 0 1 2 1 43.77 0.23 0.63 2503 3.85 260.33 1 2 1 0 71.04 0.23 1.61 2504 4.97 305.35 1 1 2 0 87.01 0.16 0.27 2505 5.91 305.44 0 1 2 1 62.43 0.07 1.57 2506 5.63 295.33 0 1 1 1 43.77 0.23 0.53 2507 4.37 302.37 1 2 1 0 131.03 1.83 0.85 2508 5.49 277.34 0 1 1 1 43.77 0.23 1.17 2509 4.71 289.37 1 1 2 0 50.16 0.78 1.56 2510 5.27 317.38 2 1 1 1 77.14 0.53 1.00 2511 5.02 310.39 1 2 1 1 71.04 0.23 1.22 2512 7.17 315.45 0 1 2 1 43.77 0.17 2.01 2513 5.49 277.34 0 1 1 1 43.77 0.23 1.23 2514 5.55 273.37 0 1 1 1 43.77 0.53 1.64 2515 5.09 303.35 2 1 3 1 146.54 2.00 0.48 2516 6.52 309.40 0 1 1 1 43.77 0.02 1.67 2517 5.81 293.79 0 1 1 1 43.77 0.22 1.94 2518 3.86 302.37 1 2 1 0 152.18 1.29 0.56 2519 5.27 289.37 1 1 2 1 61.64 0.78 1.33 Rot Bond viols PSA DIVS BBB SOLY CACO2 SP_S SP_P PB VD HERG SD MS 4.47 1.34 0.10 1.22 98.04 4.89 0.98 0.03 0.95 100.39 4.35 1.45 0.04 1.19 98.32 4.20 1.17 0.06 0.88 93.47 5.42 1.50 0.31 1.30 91.68 4.87 1.32 0.17 0.81 96.73 4.81 1.20 0.18 1.13 97.03 4.89 1.43 0.04 1.16 101.37 5.21 1.52 0.16 1.15 97.66 5.13 1.46 0.22 1.00 98.20 5.20 1.65 0.37 1.28 106.15 6.04 1.26 0.35 1.35 95.33 4.93 1.48 0.01 1.07 96.89 5.29 1.39 0.17 1.33 94.27 4.10 1.03 0.05 0.92 93.27 6.05 1.59 0.50 1.43 107.88 5.13 1.51 0.36 1.35 97.44 4.14 1.11 0.09 0.96 92.51 5.01 1.51 0.20 1.15 93.66 0.53 1.02 0.02 0.39 0.96 0.69 0.24 0.16 0.55 0.83 0.06 0.31 0.48 1.03 0.83 0.24 0.94 0.36 0.15 0.14 0.39 0.44 0.64 0.12 0.39 0.97 0.30 0.28 0.71 0.74 0.10 0.10 0.68 0.24 0.13 0.10 0.70 0.34 0.15 0.16 0.67 0.58 0.25 0.17 0.78 0.40 0.07 0.06 0.62 0.34 0.11 0.02 0.71 0.47 0.22 0.17 0.05 0.69 1.22 0.61 0.85 0.41 0.38 0.15 0.88 0.01 0.08 0.10 0.17 0.68 0.89 0.73 0.81 0.44 0.43 0.01 S4

2520 4.67 290.36 2 2 2 0 75.42 0.78 1.19 2521 5.27 289.37 1 1 2 1 61.58 0.78 1.43 2522 4.31 289.37 1 2 3 0 97.55 0.29 0.59 2523 6.40 328.24 0 1 1 1 43.77 0.22 2.03 2524 5.01 319.40 2 1 3 1 68.13 0.11 1.34 2525 4.08 278.32 1 2 1 0 70.71 0.23 0.82 2526 6.29 303.37 0 1 2 1 43.77 0.23 0.91 2527 5.35 307.36 1 1 2 1 61.58 0.78 0.55 2601 3.17 289.33 2 1 2 0 106.78 0.07 0.26 2602 4.70 329.32 1 1 2 0 63.46 0.23 0.45 2605 4.38 307.41 1 1 2 0 82.12 0.04 0.76 2606 4.10 297.30 1 1 1 0 59.52 0.14 0.32 2607 2.84 304.34 2 2 1 0 150.72 1.83 0.13 2608 3.96 279.31 1 1 1 0 63.46 0.14 0.63 2609 3.18 291.34 2 1 2 0 59.21 0.26 1.02 2610 3.74 319.35 3 1 1 0 96.83 0.33 0.83 2611 3.50 312.36 2 2 1 0 79.98 0.23 0.22 2612 5.64 317.42 1 1 2 1 63.46 0.01 1.17 2614 4.02 275.34 1 1 1 0 52.32 0.33 1.26 2615 3.56 305.33 3 1 3 0 166.23 1.19 0.24 4.55 1.40 0.15 1.05 95.21 5.11 1.53 0.22 1.19 97.57 4.39 1.03 0.14 0.96 91.06 5.87 1.60 0.61 1.39 104.03 5.35 1.42 0.26 1.14 95.05 4.36 1.26 0.03 1.02 97.47 6.11 1.26 0.36 1.21 103.25 5.06 1.34 0.16 1.05 101.25 3.99 1.27 0.01 0.78 89.50 4.42 0.65 0.14 0.68 87.97 4.15 1.27 0.07 1.14 90.52 4.41 0.74 0.36 0.51 83.96 4.20 1.09 0.05 0.77 91.82 3.94 1.23 0.11 0.76 89.04 4.34 1.30 0.09 1.06 92.36 4.69 1.15 0.00 0.83 91.80 4.55 1.47 0.25 0.91 99.86 5.20 1.32 0.07 1.24 103.29 4.24 1.40 0.09 1.24 94.87 3.69 0.69 0.09 0.49 75.15 0.55 0.59 0.03 0.09 0.86 0.53 0.48 0.03 0.56 0.84 1.00 0.36 1.13 0.34 0.46 0.01 0.83 0.64 0.15 0.28 0.39 0.94 0.61 0.15 0.54 0.46 0.74 0.20 0.87 0.89 0.12 0.06 0.62 1.24 0.35 0.47 0.58 0.22 0.44 0.17 0.60 0.33 0.69 0.32 0.38 0.90 0.82 0.00 0.52 1.30 0.79 0.54 0.56 0.51 0.43 0.34 0.43 0.89 0.65 0.12 0.61 0.64 0.18 0.08 0.74 0.92 0.24 0.29 0.49 0.59 0.29 0.16 0.46 0.72 0.46 0.35 0.07 0.87 1.61 0.70 S5

2616 4.99 311.38 1 1 1 0 52.64 0.23 0.90 2618 2.33 304.34 2 2 1 0 171.87 1.29 0.31 2619 3.74 291.34 2 1 2 0 81.33 0.26 0.70 2620 3.14 292.33 3 2 2 0 95.11 0.26 0.49 2621 3.74 291.34 2 1 2 0 81.27 0.26 0.62 2622 2.78 291.34 2 2 3 0 117.24 0.15 0.23 2623 4.87 330.21 1 1 1 0 59.52 0.17 1.45 2624 3.48 321.37 3 1 3 0 87.82 0.26 0.69 2625 2.55 280.30 2 2 1 0 90.40 0.14 0.29 2626 4.77 305.35 1 1 2 0 66.60 0.23 0.27 2627 3.82 309.33 2 1 2 0 81.27 0.26 0.23 2628 3.81 300.35 1 2 1 0 103.62 0.14 0.59 2801 6.28 322.83 1 2 2 1 49.70 0.03 1.47 2802 5.71 306.38 1 2 2 1 49.70 0.07 1.35 2803 4.86 280.41 0 2 1 0 49.59 0.08 1.78 2804 3.74 252.35 0 2 1 0 49.44 0.20 1.87 2805 4.30 266.38 0 2 1 0 49.45 0.14 1.81 2806 4.68 254.37 0 2 3 0 49.26 0.76 1.85 2807 2.92 268.35 1 2 1 0 65.40 0.20 1.06 2808 3.86 283.41 1 3 4 0 54.56 0.26 1.20 4.85 1.49 0.23 1.31 106.60 4.22 1.07 0.03 0.60 84.37 4.16 1.25 0.05 1.02 90.09 4.26 1.14 0.00 0.69 84.12 3.97 1.24 0.01 0.99 88.36 4.16 0.91 0.28 0.50 83.06 4.70 1.51 0.37 1.27 102.28 4.42 1.21 0.05 0.96 88.64 4.14 0.92 0.13 0.55 86.65 4.91 1.35 0.19 0.83 99.50 4.03 1.06 0.05 0.81 87.04 4.33 1.39 0.21 1.11 96.42 5.62 1.26 0.46 1.32 97.33 5.30 1.45 0.11 1.12 99.81 4.57 1.38 0.04 1.09 89.02 4.10 1.33 0.20 1.07 86.90 4.31 1.37 0.11 1.08 89.16 3.98 1.34 0.19 1.15 83.82 3.60 1.17 0.29 0.94 85.98 4.08 1.24 0.11 0.87 85.00 0.57 0.54 0.30 0.31 0.27 1.07 1.00 0.66 0.51 0.70 0.51 0.26 0.66 0.95 0.16 0.16 0.54 0.59 0.65 0.37 0.46 0.83 1.48 0.47 0.83 0.29 0.09 0.17 0.82 0.95 0.37 0.10 0.54 1.18 0.43 0.22 0.49 0.05 0.02 0.28 0.53 0.76 0.69 0.27 0.64 0.36 0.34 0.55 0.84 0.26 0.43 0.06 0.63 0.28 0.14 0.20 0.81 0.27 0.08 0.07 0.53 0.48 0.31 0.30 0.77 0.42 0.21 0.08 0.55 0.67 0.12 0.13 0.35 0.73 1.01 0.32 0.47 0.43 0.76 0.00 S6

2809 2.10 333.38 3 2 3 0 151.45 0.04 0.73 2810 5.42 318.41 2 2 3 1 56.29 0.74 1.71 2811 5.39 302.41 0 2 3 1 49.22 0.29 1.44 2812 5.71 306.38 1 2 2 1 49.70 0.07 1.07 2813 7.06 378.51 0 2 5 1 51.86 0.00 1.38 2814 5.72 316.44 0 2 4 1 49.29 0.29 0.98 2815 5.66 294.43 0 2 2 1 49.04 0.61 1.71 2816 5.66 294.43 0 2 5 1 49.20 0.65 1.59 2817 6.19 366.84 3 2 2 1 85.85 0.03 0.42 2818 7.75 376.49 1 2 1 1 51.07 0.00 1.43 2819 5.92 316.44 0 2 4 1 49.26 0.93 1.47 2820 3.14 238.33 0 2 1 0 50.13 0.62 1.79 2821 4.15 240.34 0 2 2 0 49.35 0.56 1.78 2822 3.18 238.33 0 2 1 0 49.68 0.15 1.74 2823 4.86 268.40 0 2 2 0 49.11 0.61 1.63 2824 7.42 356.50 1 2 3 1 49.38 0.11 1.82 2825 5.42 294.43 0 2 1 1 49.92 0.08 1.75 2901 4.75 324.80 2 2 2 0 58.61 0.03 0.69 2902 4.18 308.35 2 2 2 0 58.61 0.07 0.57 2903 3.33 282.38 1 2 1 0 69.10 0.08 0.90 5.40 1.10 0.22 1.03 95.71 5.81 1.36 0.29 1.22 99.71 5.39 1.35 0.13 1.16 105.42 5.26 1.38 0.07 1.11 99.51 7.26 1.46 0.69 1.36 121.61 5.64 1.38 0.29 1.21 108.91 4.86 1.38 0.00 1.15 94.79 4.63 1.25 0.05 1.16 87.92 5.50 1.27 0.41 1.00 106.95 6.03 1.44 0.69 1.26 114.99 5.56 1.36 0.19 1.18 104.65 3.89 1.34 0.23 1.05 84.73 3.77 1.32 0.25 1.12 85.12 3.62 1.27 0.26 1.06 79.97 4.43 1.36 0.23 1.09 87.92 6.84 0.79 0.47 1.32 83.24 4.77 1.35 0.07 1.08 87.63 4.61 1.32 0.20 1.24 101.76 4.51 1.18 0.12 0.88 94.15 4.02 1.22 0.31 0.93 85.57 0.82 0.46 0.09 0.15 0.73 0.28 0.14 0.13 0.57 0.14 0.14 0.26 0.59 0.43 0.06 0.21 0.92 0.05 0.11 0.42 0.67 0.20 0.44 0.18 0.73 0.38 0.00 0.17 0.74 0.57 0.21 0.18 0.84 0.07 0.48 0.32 0.80 0.09 0.33 0.47 0.62 0.12 0.07 0.38 0.65 0.63 0.24 0.32 0.49 0.76 0.32 0.26 0.61 0.68 0.38 0.39 0.48 0.41 0.30 0.12 0.61 0.03 1.80 0.17 0.86 0.08 0.12 0.19 0.70 0.05 0.47 0.16 0.48 0.53 0.66 0.04 0.49 0.53 0.79 0.09 S7

2904 2.21 254.33 1 2 1 0 70.95 0.15 0.95 2905 2.77 268.35 1 2 1 0 69.87 0.14 0.85 2906 3.15 256.34 1 2 3 0 57.84 0.76 0.78 2907 1.39 270.33 2 2 1 0 85.82 0.20 0.63 2908 2.33 285.38 2 3 4 0 61.14 0.26 0.43 2909 0.57 335.36 4 2 3 0 160.36 0.01 0.27 2910 3.89 320.39 3 2 3 0 65.20 0.19 0.78 2911 3.86 304.39 1 2 3 0 70.35 0.56 0.51 2912 4.18 308.35 2 2 2 0 58.61 0.07 0.27 2913 5.53 380.48 1 2 5 1 56.58 0.00 0.32 2914 4.19 318.41 1 2 4 0 56.00 0.29 0.43 2915 4.13 296.41 1 2 2 0 56.79 0.38 0.65 2916 4.13 296.41 1 2 5 0 56.96 0.65 0.70 2917 4.66 368.81 4 2 2 0 99.39 0.03 0.45 2918 6.22 378.47 2 2 1 1 59.00 0.09 0.93 2919 4.39 318.41 1 2 4 0 57.79 0.93 0.58 2920 1.61 240.30 1 2 1 0 72.66 0.62 0.79 2921 2.62 242.32 1 2 2 0 57.87 0.26 0.97 2922 1.65 240.30 1 2 1 0 71.38 0.15 0.85 2923 3.33 270.37 1 2 2 0 57.64 0.38 0.79 3.66 1.19 0.47 0.81 81.12 3.93 1.23 0.37 0.88 86.07 3.71 1.18 0.40 0.81 77.82 3.75 0.95 0.47 0.51 72.37 3.98 0.96 0.35 0.53 72.42 4.73 0.94 0.04 0.77 90.55 4.76 1.28 0.02 1.13 101.06 5.22 1.27 0.06 0.91 106.87 4.28 1.13 0.14 0.75 87.61 6.03 1.32 0.41 1.21 117.25 5.09 1.28 0.13 1.01 105.11 4.59 1.18 0.20 0.85 88.69 4.49 1.17 0.27 0.87 84.09 4.81 1.13 0.19 0.77 94.36 5.69 1.36 0.48 1.09 113.26 5.32 1.28 0.01 0.98 106.21 3.54 1.17 0.49 0.80 81.63 3.59 1.25 0.48 0.71 74.93 3.31 1.16 0.51 0.78 76.35 4.33 1.29 0.39 0.77 85.89 0.23 0.82 0.93 0.39 0.47 0.73 0.87 0.16 0.34 0.94 1.06 0.18 0.20 0.63 1.19 0.27 0.26 0.69 1.11 0.01 0.56 0.01 0.47 0.21 0.49 0.57 0.58 0.14 0.39 0.41 0.89 0.12 0.50 0.44 0.74 0.12 0.72 0.35 0.53 0.35 0.56 0.64 0.82 0.09 0.62 0.69 0.88 0.25 0.55 0.79 0.76 0.16 0.69 0.05 0.27 0.03 0.71 0.34 0.10 0.53 0.47 0.37 0.68 0.20 0.33 1.04 1.05 0.43 0.29 0.93 0.64 0.17 0.34 0.98 0.93 0.47 0.29 0.65 1.01 0.15 S8

2924 5.90 358.48 2 2 3 1 57.14 0.17 1.00 5.78 1.31 0.24 1.22 114.42 0.57 0.06 0.18 0.31 2925 3.89 296.41 1 2 1 0 68.84 0.08 0.63 4.08 1.14 0.20 0.98 86.65 0.59 0.34 0.99 0.02 4.45 300.05 1 2 2 0 70.54 0.35 0.97 4.70 1.26 0.03 1.01 93.81 0.58 0.53 0.41 0.10 1.37 30.99 1 1 1 0 29.49 0.39 0.55 0.75 0.19 0.27 0.22 9.82 0.20 0.34 0.47 0.26 S9